Top

Published in:

Open Access 01-02-2011 | Editor's Page

Summa cum fraude: how to prevent scientific misconduct

Author: E. E. van der Wall

Published in: Netherlands Heart Journal | Issue 2/2011

Excerpt

Scientific integrity has always been a critical issue in performing research. Recently, alarming signals from China have reached the academic community in the USA and Europe about scientific misconduct. One of the most respected newspapers in our country (NRC Handelsblad, 11 December 2010) reported that at least one third of leading scientists (2000 out of 6000) allied to one of the six major Chinese Universities has been involved in scientific misconduct such as plagiarism, data fabrication and data manipulation. Not only in China, but in almost every country, there are clear examples of scientific fraud in the university setting [1]. …

Steen RG (2010) Retractions in the scientific literature: do authors deliberately commit research fraud? J Med Ethics (in press)

Drenth PJ. Wetenschappelijke integriteit. Amsterdam: KNAW Press; 2010. ISBN 978-90-6984-612-5.

A statement on ethics from the HEART Group. Neth Heart J. 2008; 16:153–5.

de Boer MJ, van der Wall EE. Towards better cardiovascular journals. Neth Heart J. 2008;16:151–2.PubMedCrossRef

Alfonso F, Ambrosio G, Pinto FJ, van der Wall EE. European national society cardiovascular journals: background, rationale and mission statement of the ‘Editors’ Club’ (Task Force of the European Society of Cardiology). Neth Heart J. 2008;16:211–6.PubMedCrossRef

Alfonso F, Ambrosio G, Pinto FJ, van der Wall EE. European national society cardiovascular journals: background, rationale and mission statement of the ‘Editors‘ Club’ (Task Force of the European Society of Cardiology). Neth Heart J. 2010;18:202–8.PubMedCrossRef

Drazen JM, de Leeuw PW, Laine C, et al. Toward more uniform conflict disclosures—the updated ICMJE conflict of interest reporting form. N Engl J Med. 2010;363:188–9.PubMedCrossRef

Title: Summa cum fraude: how to prevent scientific misconduct
Author: E. E. van der Wall
Publication date: 01-02-2011
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 2/2011
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-010-0062-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Summa cum fraude: how to prevent scientific misconduct

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2011

Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS study

Answer to the Rhythm Puzzle

Coronary anomaly diagnosed by computed tomography coronary angiography in a patient with atypical chest pain

Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia

Long-term Clinical Outcome and MIBI SPECT Parameters in Percutaneous Coronary Interventions

The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page